No Link Found for Metformin or Statins and Ovarian Cancer

This article originally appeared here.
Share this content:
No Link Found for Metformin or Statins and Ovarian Cancer
No Link Found for Metformin or Statins and Ovarian Cancer

MONDAY, Feb. 26, 2018 (HealthDay News) -- In women with type 2 diabetes, no evidence was found of an association between the use of metformin or statins and the incidence of ovarian cancer, according to a study published online Feb. 7 in BJOG: An International Journal of Obstetrics and Gynaecology.

Elina Urpilainen, from the University of Oulu in Finland, and colleagues used national registers to identify 137,643 women (>40 years old) diagnosed with type 2 diabetes in Finland from 1996 through 2011.

The researchers found that 303 women were diagnosed with ovarian cancer during the follow-up period. Metformin was not associated with the incidence of ovarian cancer (hazard ratio, 1.02) compared to other oral antidiabetic medications. There was also no association noted between ovarian cancer incidence and statins (hazard ratio, 0.99).

"No evidence of an association between the use of metformin or statins and the incidence of ovarian cancer in patients with type 2 diabetes was found," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Critics Demand Stop to 'Guinea Pig' Sepsis Clinical Trial

Critics Demand Stop to 'Guinea Pig' Sepsis Clinical ...

Clovers trial seeks to determine which IV fluids, vasopressors combo works best to curb sepsis

Education Can Up Emotional Intelligence in Residents

Education Can Up Emotional Intelligence in Residents

Increase in total EI median scores, stress management composite score after intervention

Cancer-Related Gene Variations Frequently Reclassified

Cancer-Related Gene Variations Frequently Reclassified

24.9 percent of variants of uncertain significance were reclassified at a single commercial laboratory

is free, fast, and customized just for you!




Already a member?

Sign In Now »